arecoline and xanomeline

arecoline has been researched along with xanomeline in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bymaster, FP; Honoré, T; Klimkowski, VJ; Lamb, ML; Merritt, L; Mitch, CH; Olesen, PH; Sawyer, B; Shannon, HE; Ward, JS1
Bymaster, FP; Calligaro, DO; Deeter, JB; Merritt, L; Mitch, CH; Olesen, PH; Peters, SC; Sauerberg, P; Sawyer, BD; Shannon, HE; Sheardown, MJ; Swedberg, MD; Ward, JS1
Abuh, YF; Dunbar, PG; Edgar, MA; El-Assadi, AA; Fang, Z; Huzl, JJ; Liu, Y; Messer, WS; Nagy, PI; Ngur, DO; Ojo, B; Periyasamy, S; Rho, T; Roknich, S; Sbeih, S; Zhang, H1
Bymaster, FP; Calligaro, DO; DeLapp, NW; Fink-Jensen, A; Jeppesen, L; Olesen, PH; Rasmussen, T; Rimvall, K; Sauerberg, P; Shannon, HE; Sheardown, MJ; Thomsen, C; Ward, JS; Whitesitt, CA1
Dei, S; Marconi, C; Pedretti, A; Romanelli, MN; Scapecchi, S; Vistoli, G1

Other Studies

5 other study(ies) available for arecoline and xanomeline

ArticleYear
Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.
    Journal of medicinal chemistry, 1992, Oct-30, Volume: 35, Issue:22

    Topics: Animals; Hippocampus; In Vitro Techniques; Male; Models, Molecular; Molecular Conformation; Muscle Contraction; Muscle, Smooth; Parasympathomimetics; Pyrazines; Pyridines; Rabbits; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Structure-Activity Relationship

1992
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
    Journal of medicinal chemistry, 1995, Sep-01, Volume: 38, Issue:18

    Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Male; Mice; Muscarinic Agonists; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Structure-Activity Relationship; Thiadiazoles

1995
Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Journal of medicinal chemistry, 1997, Apr-11, Volume: 40, Issue:8

    Topics: Animals; Arecoline; Brain; Carbachol; Cell Line; Models, Molecular; Muscarinic Agonists; Phosphatidylinositols; Pyrimidines; Quinuclidinyl Benzilate; Rats; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Structure-Activity Relationship

1997
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation.
    Bioorganic & medicinal chemistry letters, 1998, Oct-20, Volume: 8, Issue:20

    Topics: Animals; Cells, Cultured; CHO Cells; Cricetinae; Humans; Inhibitory Concentration 50; Muscarinic Agonists; Pyridines; Rats; Receptor, Muscarinic M1; Receptors, Muscarinic; Structure-Activity Relationship; Thiadiazoles; Transfection

1998
Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
    Bioorganic & medicinal chemistry, 2008, Mar-15, Volume: 16, Issue:6

    Topics: Binding Sites; Computer Simulation; Humans; Ligands; Muscarinic Agonists; Protein Binding; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M5; Receptors, Muscarinic

2008